ARTELO BIOSCIENCES INC
For the period ended Dec 31, 2024. Filed Mar 3, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 3, 2025
ARTL$2.14+3.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES
| (a) | Financial Statements |
|---|---|
| (1) | Financial statements for our company are listed in the index under Item 8 of this document. |
| (2) | All financial statement schedules are omitted because they are not applicable, not material or the required information is shown in the financial statements or notes thereto. |
(b) Exhibits
| ExhibitNumber | Description | Form | File No. | FilingDate | FiledHerewith |
|---|---|---|---|---|---|
| 3.1 | Articles of Incorporation, as amended | 10-Q | 001-38951 | 5/11/2023 | |
| 3.2 | Amended and Restated Bylaws | 8-K | 001-38951 | 04/21/2023 | |
| 4.1 | Description of Securities | * | |||
| 4.2 | Specimen Common Stock Certificate | S-8 | 333-251387 | 12/16/2020 | |
| 10.1 | Purchase Agreement between the Company and Lincoln Park Capital Fund, LLC, dated May 13, 2022. | 8-K | 001-38951 | 05/16/2022 | |
| 10.2 | Registration Rights Agreement between the Company and Lincoln Park Capital Fund, LLC, dated May 13, 2022. | 8-K | 001-38951 | 05/16/2022 | |
| 10.3# | Amended and Restated Employment Agreement by and between the Company and Gregory D. Gorgas dated August 30, 2019. | 10-K | 001-38951 | 11/25/2019 | |
| 10.4 | Securities Purchase Agreement by and between the Company and Gregory D. Gorgas dated April 3, 2017. | 8-K | 333-199213 | 4/7/2017 | |
| 10.5# | Form of Indemnification Agreement | 8-K | 333-199213 | 5/8/2017 | |
| 10.6 | Stock Purchase Agreement dated May 4, 2017 | 8-K | 333-199213 | 5/8/2017 | |
| 10.7 | Form of Private Placement Subscription Agreement | 8-K | 333-199213 | 8/4/2017 | |
| 10.8 | Form of Registration Rights Agreement | 8-K | 333-199213 | 8/4/2017 | |
| 10.9 | Stock Purchase Agreement dated as of August 1, 2017 | 8-K | 333-199213 | 8/4/2017 | |
| 10.10 | Material and Data Transfer, Option and License Agreement dated as of December 20, 2017 by and between the Company and NEOMED Institute+ | 10-Q | 333-199213 | 1/16/2018 | |
| 10.11+ | First Amendment to Material and Data Transfer, Option and License Agreement by and between the Company and NEOMED Institute, dated as of January 4, 2019 | 10-Q | 333-199213 | 4/15/2019 | |
| 10.12# | 2018 Equity Incentive Plan and Forms of Award Agreement Thereunder | 8-K | 001-38951 | 12/3/2020 | |
| 10.13+ | License Agreement with Stony Brook University, by and between the Company and Stony Brook University, dated January 18, 2018 | S-1/A | 333-222756 | 4/17/2018 | |
| 19.1 | Insider Trading Policy, as amended | * | |||
| 21.1 | List of subsidiaries | 10-Q | 001-38951 | 11/08/2023 | |
| 23.1 | Consent Of Independent Registered Public Accounting Firm | * | |||
| 31.1 | Section 302 Certification | * | |||
| 32.1 ** | Section 906 Certification | * | |||
| 97.1# ** | Compensation Recovery Policy | 10-K | 001-38951 | 03/25/2024 | |
| 101 INS | Inline XBRL Instance Document | ||||
| 101 SCH | Inline XBRL Taxonomy Extension Schema Document | ||||
| 101 CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | ||||
| 101 DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | ||||
| 101 LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | ||||
| 101 PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | ||||
| 104 | Cover page Interactive Data File (embedded with the Inline XBRL document) | ||||
| # | Management contracts or compensatory plans, contracts or arrangements. |
|---|---|
| + | Certain portions of this exhibit have been omitted. |
| ** | The certification attached as Exhibit 32.1 that accompanies this Annual Report, is deemed furnished and not filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of Artelo Biosciences, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Annual Report, irrespective of any general incorporation language contained in such filing. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.